IgA kappa/IgA lambda heavy/light chain assessment in the management of patients with IgA myelomaEileen M. Boyle, Xavier Leleu, Charles Herbaux et al.|Cancer|2014Cited by 36
Safety Profile of Bortezomib Impacts Survival in Light Chain AmyloidosisZoé Van de Wyngaert, Xavier Leleu, Greg Vanoutryve et al.|Blood|2014Cited by 0
First results of the rwe prospective study TEC care (IFM 2023-01) evaluating teclistamab in triple-class exposed relapsed refractory multiple myeloma patients.Aurore Perrot, Cyrille Touzeau, Cyrille Hulin et al.|Blood|2025Cited by 0